Search

A recent study conducted at Peking Union Medical College Hospital in Beijing, China, focused on the rare and life-threatening complication of bronchiolitis obliterans (BO) in patients with unicentric Castleman disease (UCD). The study found that UCD patients with BO had distinct clinical characteristics, including deep lymph node involvement and paraneoplastic pemphigus. The research highlighted the importance of lung transplantation in improving the prognosis for patients with severe BO. This study provides valuable insights into the management and outcomes of UCD patients complicated with BO. [Extracted from the article]

A recent study conducted by researchers at Tianjin University in China explored the relationship between endotoxins in household dust and childhood asthma and allergies. The study found a significant positive association between endotoxin concentrations and children's current asthma. Factors such as old houses, ventilation systems without exhaust fans, and infrequent window opening were related to higher concentrations of endotoxins. The researchers recommend strategies for controlling endotoxin concentrations, such as building maintenance and ventilation improvements, to reduce the risk of asthma in children. [Extracted from the article]

Researchers at Jinzhou Medical University in China have conducted a study to evaluate the accuracy and modification of the STOP-Bang questionnaire for screening patients with obstructive sleep apnea (OSA). The study found that the original STOP-Bang questionnaire had higher sensitivity and lower specificity for men, while women had higher specificity and lower sensitivity. The researchers determined that the optimal modified STOP-Bang questionnaire total scores for men were >= 4 and >= 3 for women. This research provides valuable insights into the gender-related performance of the STOP-Bang questionnaire in screening for OSA. [Extracted from the article]

A recent study conducted in China examined the factors associated with delayed radiographic resolution of lobar pneumonia caused by Mycoplasma pneumoniae in children. The study analyzed data from 339 children with this type of pneumonia and found that factors such as hospitalization time, C-reactive protein (CRP) level, lactate dehydrogenase (LDH) level, pulmonary lesions involving two or more lobes, and a large amount of pleural effusion were independent risk factors for delayed resolution. The study suggests that pediatricians should be vigilant for these factors and take early intervention measures to prevent complications and sequelae of Mycoplasma pneumoniae pneumonia. [Extracted from the article]

A study conducted by researchers at Huazhong University of Science and Technology in China has found that non-optimum temperatures are associated with an increased risk of respiratory diseases. The study analyzed the impact of apparent temperature (AT) on outpatient and inpatient visits for respiratory diseases in the city of Ganzhou. The researchers found that moderate heat was significantly associated with an increased risk of daily outpatient and inpatient visits for respiratory diseases, particularly among children under the age of 5. The study highlights the importance of considering temperature effects on respiratory health. [Extracted from the article]

A study conducted by Guangzhou Medical University in Guangdong, China, explores the role of periostin in Mycoplasma pneumoniae pneumonia (MPP) in children. Periostin is found to be associated with airway remodeling, and T helper 17 (Th17) cells play a crucial role in fighting M. pneumoniae infection. The study reveals that periostin expression is positively correlated with the severity of MPP, and it inhibits the apoptosis of Th17 cells. Additionally, periostin induces the expression of proinflammatory cytokines and is required for Th17 cell migration. This research provides insights into the mechanisms underlying MPP and its potential therapeutic targets. [Extracted from the article]

Researchers from Xiamen University in China have developed a potential vaccine for Klebsiella pneumoniae, a drug-resistant pathogen that causes acute pneumonia and is a leading cause of hospital-acquired infections. The vaccine, called hybrid membrane vesicles (HMVs), consists of outer membrane vesicles of Klebsiella pneumoniae and cell membrane vesicles of alveolar macrophages. In mouse models, the HMVs provided significant protection, reduced the number of colonies in deep tissues, improved survival, and reduced symptoms of acute inflammation. This research demonstrates the potential of HMVs as an effective platform for activating bacteria-specific immunity and protecting against nosocomial pneumonia caused by Klebsiella pneumoniae. [Extracted from the article]

A report from Hebei General Hospital in Shijiazhuang, China, discusses the value of combined detection of procalcitonin (PCT), C-reactive protein (CRP), and fibrinogen (FIB) in differentiating severe pneumonia caused by viral infection from bacterial infection. The study included 100 patients with severe pneumonia, divided into viral and bacterial groups, as well as a healthy control group. The levels of PCT, CRP, and FIB were significantly higher in the bacterial group compared to the viral group, and the combined detection of these markers showed higher diagnostic efficiency than individual markers. The researchers concluded that combined detection of PCT, CRP, and FIB can aid in the early differential diagnosis of pneumonia infection types. [Extracted from the article]

A recent study conducted in China investigated factors associated with dysphagia screening (DS) and the development of pneumonia in patients with intracerebral hemorrhage (ICH). The study found that 81.6% of patients with ICH underwent DS, and 23.0% developed pneumonia. Older age, severe strokes, dysphagia, heart failure, and smoking were identified as risk factors for pneumonia. The study concluded that there is a need to increase the rate of DS in patients with ICH, especially those with severe stroke or older, and further research is needed to determine the effectiveness of DS on clinical outcomes. [Extracted from the article]

A recent study conducted by researchers at Gansu University of Chinese Medicine in China explored the therapeutic effect of naringin (NAR) on bacterial-induced lung inflammation caused by Klebsiella pneumoniae (Kpn) infection. The study found that mice infected with Kpn exhibited increased white blood cells and neutrophils, as well as severe lung injury and elevated expression of inflammatory cytokines. However, treatment with NAR decreased the protein expression of NLRP3, alleviated lung inflammation, and reduced lung injury in mice. The study suggests that NAR could protect against Kpn-induced pneumonia by inhibiting the overactivation of the NLRP3 inflammasome signaling pathway. This research provides a theoretical basis for the development of NAR as an anti-inflammatory adjuvant. [Extracted from the article]

A new report from the Department of Infectious Diseases in Deyang, China, analyzes the clinical characteristics, treatments, and short-term prognoses of 18 patients with novel coronavirus pneumonia (NCP). The study found that fever and cough were common symptoms, and the main laboratory indices were lymphocytopenia and leukocytopenia. The patients were treated with antiviral therapy and targeted treatment, and all of them were cured and discharged. The research suggests that close contact history, nucleic acid detection, and chest imaging are important for diagnosis, and that antiviral therapy has positive therapeutic effects. [Extracted from the article]

A case report from Lanzhou University in China discusses a rare case of a 23-year-old female patient who contracted both bacterial and Curvularia lunata infections during influenza A virus infection. The patient experienced severe complications, including lung abscess, pneumothorax, sepsis, and multiorgan failure, and ultimately succumbed to septic shock and multiple organ dysfunction syndrome. The researchers emphasize the need for prompt empirical antifungal therapy in patients with severe pneumonia caused by influenza A virus and invasive lung damage. This case highlights the importance of considering the possibility of Curvularia lunata infection in such patients. [Extracted from the article]

A study conducted at Yantai Yuhuangding Hospital Biochip Laboratory in China investigated the role of microRNA (miR)-29a-3p in neonatal pneumonia (NP). The researchers found that miR-29a-3p was elevated in NP patients and played a role in inflammatory damage by targeting Kruppel-like Factor 4 (KLF4). Silencing miR-29a-3p alleviated lung injury and inflammation in newborn rats. This study provides insights into the molecular processes of NP and offers potential avenues for diagnosing and treating the condition. [Extracted from the article]

A recent study conducted by researchers at Guangzhou University of Chinese Medicine in China explored the potential mechanisms of Exocarpium Citri Grandis (ECG), a traditional Chinese medicine, for the treatment of chronic bronchitis (CB). The study utilized a comprehensive systems pharmacology approach to investigate the effects of ECG on CB. The findings revealed that ECG targets inflammatory responses, immune processes, and apoptosis, and it effectively reduced the secretion of inflammatory markers in an in vitro model. Additionally, ECG demonstrated anti-apoptotic effects by regulating the expression of specific genes. This study provides valuable insights into the pharmacological mechanisms of ECG for the treatment of CB and supports its potential clinical application. [Extracted from the article]

A recent study conducted by researchers at Xuzhou Medical University in China explored the efficacy and safety of montelukast in preventing or treating bronchopulmonary dysplasia (BPD) in preterm infants. BPD is a common chronic lung disease in preterm infants with limited treatment options. The study found that while montelukast did not alleviate the severity of BPD, it did shorten the duration of respiratory support and decrease the pulmonary severity score in very preterm infants. There were no significant adverse drug events associated with montelukast treatment. Further research is needed to fully understand the potential benefits of montelukast in treating BPD. [Extracted from the article]

Researchers from the First Affiliated Hospital of Nanchang University in China have published a new study on mitochondrial myopathy, a group of diseases caused by abnormal mitochondrial structure or function. The study focuses on a case of a male patient who experienced difficulty weaning off a ventilator after severe pneumonia. The patient was ultimately diagnosed with mitochondrial myopathy through muscle biopsy and genetic testing. Treatment with various supplements improved the patient's symptoms, and he was discharged from the hospital. The study highlights the importance of muscle biopsy and genetic testing in diagnosing mitochondrial myopathy and identifies a specific mutation in the mitochondrial DNA that contributed to the patient's condition. [Extracted from the article]

This document provides information about a clinical trial being conducted in China. The trial is recruiting participants with gastroesophageal junction adenocarcinoma and aims to evaluate the effectiveness of a treatment regimen that includes the drugs Camrelizumab, Apatinib, Oxaliplatin, Paclitaxel (Albumin Bound), and radiotherapy. The estimated enrollment for the trial is 68 participants, and the estimated completion date is May 1, 2028. The trial has specific eligibility criteria, and interested individuals can contact the primary or backup contact for more information. [Extracted from the article]

This document provides information about a Phase II clinical trial in China for patients with advanced Stage IV colorectal cancer. The trial aims to evaluate the effectiveness and safety of combining Cadonilimab, Fruquintinib, and stereotactic body radiation therapy (SBRT) as a third-line and posterior line treatment for patients with oligometastatic colorectal cancer. The trial is currently recruiting participants and will assess various outcomes such as progression-free survival, objective response rate, disease control rate, overall survival, and quality of life. The trial has specific eligibility criteria and is being conducted by the Huazhong University of Science and Technology. The document does not provide information about data sharing or the involvement of a data monitoring committee. [Extracted from the article]

A recent study conducted in China by researchers from the First Affiliated Hospital of Wenzhou Medical University has provided new insights into chronic obstructive pulmonary disease (COPD). While smoking has traditionally been considered the main cause of COPD, the study suggests that prior respiratory system events (such as childhood hospitalization for pneumonia and chronic bronchitis) and environmental exposure (such as workplace dust and indoor combustion particles) may also play a role in the development of the disease. The study recommends increased screening for individuals with chronic respiratory symptoms and emphasizes the importance of smoking cessation and reducing exposure to biofuels. [Extracted from the article]

A clinical trial, NCT06155396, is currently underway in China to evaluate the effectiveness and safety of RC48-ADC in combination with Zimberelimab Injection for the treatment of recurrent or metastatic cervical cancer. The trial aims to assess various factors such as response rate, duration of response, disease control rate, progression-free survival, and overall survival in individuals with HER2-expressing cervical cancer who have not responded to standard therapy. The trial involves the administration of Disitamab Vedotin and Zimberelimab and is expected to enroll 116 participants, with an estimated completion date of December 31, 2027. Eligibility criteria include confirmed HER2 expression, measurable disease, and adequate organ function. [Extracted from the article]

This document provides information about a clinical trial, NCT06158919, that is currently recruiting participants in China. The trial aims to investigate the safety and efficacy of combining fuquinitinib with PD-1 inhibitors and chemotherapy in the treatment of inoperable HER2-negative advanced gastric cancer or adenocarcinoma of the esophagogastric junction. Eligible patients will receive six cycles of combined treatment with fuquinitinib, PD-1 inhibitors, and chemotherapy, followed by maintenance treatment with fuquinitinib and PD-1 inhibitors. The trial is expected to be completed by November 20, 2026 and is open to individuals between the ages of 18 and 80 with a confirmed diagnosis of gastric/esophagogastric junction adenocarcinoma. [Extracted from the article]

A recent report from Peking University in China discusses the importance of accurately assessing the severity of community-acquired pneumonia (CAP) and whether updating the cut-off values of severity scoring systems can improve predictive accuracy. The study involved 3,212 patients with CAP and found that updating the cut-off values for certain parameters, such as respiratory rate and blood pressure, resulted in better predictions of mortality. The researchers concluded that updating the cut-off values of severity scoring systems for CAP can improve predictive accuracy, potentially leading to better clinical decision-making and reduced mortality rates. [Extracted from the article]

A study conducted by Guangzhou Medical University in Southern China explored the relationship between allergies in children and their parents. The researchers found that there is a positive correlation between childhood and parental allergies, with genetics playing a significant role in the development of these conditions. The study also revealed that when both parents had allergies, the children had a higher rate of allergy diagnosis and sensitization. However, maternal allergies or sensitization did not significantly affect the children's symptoms or quality of life. Further research is needed to confirm these findings. [Extracted from the article]

A study conducted at Children's Hospital - Zhengzhou University in China aimed to evaluate the clinical value of the procalcitonin-to-albumin ratio (PAR) in identifying sepsis in neonates with pneumonia. The researchers retrospectively included 912 neonates with pneumonia and found that neonates with sepsis had a higher PAR. The study concluded that PAR can be used as a new biomarker to identify sepsis in neonates with pneumonia. The research provides valuable insights for clinicians in identifying sepsis in this population. [Extracted from the article]

A recent study conducted at Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine in China explored the relationship between obstructive sleep apnea (OSA) and lung cancer progression. The study found that OSA promotes the activation of cancer-associated fibroblasts (CAFs) in lung cancer patients. The researchers discovered that hypoxia, a condition associated with OSA, activates TGFb signaling in lung cancer cells and fibroblasts, leading to increased cancer cell migration and invasion, as well as an enrichment of CAFs. The study suggests that intermittent hypoxia, a characteristic of OSA, promotes the progression of lung cancer by upregulating TGFb signaling and increasing CAF activation. [Extracted from the article]

A recent report from the Affiliated Hospital of Chengde Medical University in China highlights the case of a patient with chronic myeloid leukemia who developed Legionella pneumonia. Legionella is a gram-negative bacterium that causes community-acquired pneumonia, and Legionella pneumophila is the most common causative agent. The patient's condition worsened despite treatment with various antimicrobial agents, and they eventually died. The researchers emphasize the importance of considering Legionella infection in critically ill patients with pneumonia, especially when conventional therapies are ineffective, and suggest that metagenomic next-generation sequencing can be a useful diagnostic tool in such cases. [Extracted from the article]

This document provides information about a clinical trial for the treatment of breast cancer in women. The trial is currently recruiting participants and aims to evaluate the effectiveness of certain drugs in treating hormone receptor-positive, HER2-negative breast cancer. The eligibility criteria for participants are outlined, and the trial is being conducted in China. The document also includes administrative information such as the study ID number and contact information for the responsible party. [Extracted from the article]

A study conducted at the Third Affiliated Hospital of Soochow University in China explored the relationship between serum fibroblast growth factor 21 (FGF21) and adverse events in hemodialysis (HD) patients, including all-cause mortality, major adverse cardiovascular events (MACEs), and pneumonia. The study included 388 Chinese HD patients from two HD centers and found that higher levels of serum FGF21 were independently associated with increased risk of all-cause mortality, MACEs, and pneumonia in HD patients. The researchers developed nomograms based on FGF21 levels to assess individualized risk for HD patients. This study provides valuable insights into the predictive value of FGF21 in HD patients and highlights the importance of monitoring FGF21 levels in this population. [Extracted from the article]

A meta-analysis and systematic review conducted by researchers at Shantou Central Hospital in China found an association between the use of anticholinergic medications and an increased risk of pneumonia in elderly adults. The study analyzed data from six studies involving 107,012 participants and found that anticholinergic medication use was related to a higher risk of pneumonia, particularly with higher-potency anticholinergic drugs and during the initiation phase of medication. The researchers recommend that clinicians carefully monitor the use of anticholinergic medications in older patients, especially when pneumonia-related signs and symptoms are present. [Extracted from the article]

A study conducted by researchers at Nanjing Medical University in China has found that serum Cystatin C levels within 24 hours of admission could potentially predict acute kidney injury (AKI) in Chinese patients with community-acquired pneumonia (CAP). The study included 2,716 patients with CAP, of which 766 (28%) developed AKI. After multivariate logistic regression analysis, serum Cystatin C was identified as an independent factor for AKI in CAP patients. The researchers concluded that serum Cystatin C within 24 hours of admission could serve as a reliable biomarker for predicting AKI in Chinese patients with CAP. [Extracted from the article]

A recent study conducted at Nanjing Medical University in China explored the relationship between thoracic fluid content (TFC) and the risk of pneumonia in patients undergoing maintenance hemodialysis (MHD). The study found that patients who were older, had diabetes, poorer nutritional status, higher levels of inflammation, poorer cardiac function, and higher fluid volume load were more likely to develop pneumonia. The researchers also identified TFC, neutrophil-to-lymphocyte ratio (NLR), hemoglobin, and serum albumin as independent risk factors for pneumonia in MHD patients. The study suggests that TFC can be a useful predictor of pneumonia in this population. [Extracted from the article]

This article discusses a clinical trial, NCT06145841, that is currently underway in China. The trial aims to study the effectiveness of using Metagenomic Next-Generation Sequencing-based technology to guide anti-infection treatments in AIDS patients with severe pneumonia and/or sepsis. The study compares the pathogen detection rates and clinical diagnosis conformity rates between the group using metagenomic sequencing and the group using conventional methods. The trial is observational and is expected to be completed by October 2027. The responsible party for the trial is the Guangzhou 8th People's Hospital. [Extracted from the article]

Researchers from Cangzhou Medical College in China have developed a predictive model to identify high-risk patients for acute respiratory distress syndrome (ARDS) in individuals with acute pancreatitis (AP) complicated by acute kidney injury (AKI). The study enrolled 292 patients and used multivariate logistic regression to identify independent predictors of ARDS, including intra-abdominal pressure (IAP), shock, C-reactive protein (CRP), and lactate dehydrogenase (LDH). A nomogram was developed based on these predictors, which showed good discriminative ability and concordance with observed values. The researchers suggest that this nomogram can help clinicians identify high-risk patients and optimize therapeutic strategies. [Extracted from the article]

A recent study conducted in a hospital in western China evaluated the inhaler skills of patients with asthma and chronic obstructive pulmonary disease (COPD) after receiving medication education from pharmacists. The study found that a significant number of patients using Turbuhaler and Diskus inhalers were unable to use them correctly. Factors such as advanced age, low educational level, and female gender were associated with a lack of inhaler technique. The study highlights the importance of proper inhaler education and the need for targeted interventions to improve inhaler skills among patients in western China. [Extracted from the article]

New research from Hong Kong, People's Republic of China, explores the use of artificial intelligence (AI) to identify common targets for the treatment of asthma, eczema, and food allergy. The study aims to develop novel therapeutics that target multiple allergies, as these conditions often coexist and have a shortage of effective treatments. Using an AI-driven target discovery platform called PandaOmics, the researchers identified six common high-confidence targets across all three allergic diseases, as well as three potential therapeutic targets. The study highlights the shared pathophysiology of allergic disorders and demonstrates the power of AI in identifying novel therapeutic targets. [Extracted from the article]

A recent study conducted by researchers at Zhengzhou University in China explored the association between bronchopulmonary dysplasia (BPD) and death or neurodevelopmental impairment (NDI) in preterm infants without severe brain injury. The study included 1,211 infants who were followed up to 3 years of age. The findings revealed that BPD was independently associated with death or NDI at 3 years of age. The researchers suggest that further research is needed to understand the mechanisms linking BPD with these outcomes and to explore potential treatments. [Extracted from the article]

A study conducted by researchers at the London School of Hygiene and Tropical Medicine examined the health-related quality of life (HRQOL) and economic burden of childhood pneumonia in different regions of China. The study included 501 pediatric patients hospitalized for pneumonia in Shanghai, Zhengzhou, and Kunming. The findings revealed that children with pneumonia had poor baseline HRQOL, and a significant number of them experienced psychological well-being problems even after treatment. The economic burden varied across regions, with families in less developed areas experiencing heavier financial burdens. [Extracted from the article]